 |
Articles: Dermatologic Oncology |
The Tcl1 oncogene defines secondary hair germ cells differentiation at catagen–telogen transition and affects stem-cell marker CD34 expression
Oncogene, 02/02/09
Melanoma-associated chondroitin sulphate proteoglycan as a new target antigen for CD4+ T cells in melanoma patients
International Journal of Cancer, 02/02/09 The Bcl-xL inhibitor of apoptosis is preferentially expressed in cutaneous squamous cell carcinoma compared with that in keratoacanthoma
International Journal of Cancer, 01/29/09 Bone Marrow-Derived Cells Are Not the Origin of the Cancer Stem Cells in Ultraviolet-Induced Skin Cancer
American Journal of Pathology, 01/28/09 Tumoural expression and circulating level of VEGFR-3 (Flt-4) in metastatic melanoma patients: Correlation with clinical parameters and outcome
European Journal of Cancer, 01/27/09 Integrating BRAF/MEK inhibitors into combination therapy for melanoma
British Journal of Cancer, 01/27/09 Increased UVA exposures and decreased cutaneous vitamin D3 levels may be responsible for the increasing incidence of melanoma
Medical Hypotheses, 01/26/09 Melanoma Antigen-11 Inhibits the Hypoxia-Inducible Factor Prolyl Hydroxylase 2 and Activates Hypoxic Response
Cancer Research, 01/23/09 Fetal Microchimeric Cells Participate in Tumour Angiogenesis in Melanomas Occurring during Pregnancy
American Journal of Pathology, 01/23/09 Mechanistic Effects of Long-Term Ultraviolet B Irradiation Induce Epidermal and Dermal Changes in Human Skin Xenografts
American Journal of Pathology, 01/23/09 A phase 2, randomized study of SB-485232, rhIL-18, in patients with previously untreated metastatic melanoma
Cancer, 01/22/09 Randomized phase III study of 1 mo versus 1 yr of adjuvant high-dose interferon alfa-2b in patients with resected high-risk melanoma
Journal of Clinical Oncology, 01/22/09
Evidence Based Medicine
NEMO-binding domain peptide inhibits proliferation of human melanoma cells
Cancer Letters, 01/22/09 The role of observation in the management of atypical nevi
Southern Medical Journal, 01/21/09 Prolonged survival of dendritic cell-vaccinated melanoma patients correlates with tumor-specific delayed type IV hypersensitivity response and reduction of tumor growth factor β-expressing T cells
Journal of Clinical Oncology, 01/21/09
Evidence Based Medicine
The hair follicle barrier to involvement by malignant melanoma
Cancer, 01/21/09 ABCB8 Mediates Doxorubicin Resistance in Melanoma Cells by Protecting the Mitochondrial Genome
Molecular Cancer Research, 01/21/09 Down-regulation of Rap1GAP via Promoter Hypermethylation Promotes Melanoma Cell Proliferation, Survival, and Migration
Cancer Research, 01/21/09 Immunogenicity of HLA-A1-restricted peptides derived from S100A4 (metastasin 1) in melanoma patients
Cancer Immunology, Immunotherapy, 01/16/09 Therapeutic efficacy of ipilimumab, an anti-CTLA-4 monoclonal antibody, in patients with metastatic melanoma unresponsive to prior systemic treatments: clinical and immunological evidence from three patient cases
Cancer Immunology, Immunotherapy, 01/16/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Journal of Clinical Oncology, Cancer Research, Annals Oncology
more...
|
250 Available Pages
|
|
